Exact Mass: 482.27592219999997
Exact Mass Matches: 482.27592219999997
Found 147 metabolites which its exact mass value is equals to given mass value 482.27592219999997
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Alectinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Cilobradine
3-Me ether-22beta-2,3,22,23-Tetrahydroxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione|3-methyl-22beta,23-dihydroxy-6-oxo-tingenol
7alpha-(acetoxy)-23xi-methoxy-21,23-epoxy-24,25,26,27-tetranorapotirucalla-1,14,20(22)-trien-3,21-dione|O-methylazadironolide
11,12-epoxy-2,6-dihydroxy-24-norursa-1,4-dien-3-on-(28->13)-olide|2,6beta-dihydroxy-3-oxo-11alpha,12alpha-epoxy-24-norursa-1,4-dien-28,13beta-olide
(5S,10S,13R,16R,17S,20S,22R,23S,24S)-16,22-epoxy-21,23-lactone-24-hydroxystigmasta-8,14-dien-3,28-dione|vernoanthelcin C
(4aS,6aS,6bR,8R,12aS,12bS,12cS,13aS,13bS,13cR)-1,3,4,5,6,6a,6b,7,8,12a,12b,12c,13a,13c-tetradecahydro-8,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-2H,10H-13b,4a-(epoxymethano)piceno[13,14-b]oxirene-10,15-dione|2,6beta-dihydroxy-3-oxo-11alpha,12alpha-epoxy-24-noroleana-1,4-dien-28,13beta-olide|asprellol C
Blepharotriol
Blepharotriol is a natural product found in Maytenus woodsonii with data available.
(5E,9Z,24Z)-6-bromoheptacosa-5,9,24-trienoic acid
C27H47BrO2 (482.27592219999997)
C29H38O6_(7alpha,9xi,13alpha,17alpha)-17-(5-Methoxy-2-oxo-2,5-dihydro-3-furanyl)-4,4,8-trimethyl-3-oxoandrosta-1,14-dien-7-yl acetate
His Ile Ile Thr
His Ile Leu Thr
His Ile Thr Ile
His Ile Thr Leu
His Leu Ile Thr
His Leu Leu Thr
His Leu Thr Ile
His Leu Thr Leu
His Thr Ile Ile
His Thr Ile Leu
His Thr Leu Ile
His Thr Leu Leu
Ile His Ile Thr
Ile His Leu Thr
Ile His Thr Ile
Ile His Thr Leu
Ile Ile His Thr
Ile Ile Thr His
Ile Leu His Thr
Ile Leu Thr His
Ile Thr His Ile
Ile Thr His Leu
Ile Thr Ile His
Ile Thr Leu His
Leu His Ile Thr
Leu His Leu Thr
Leu His Thr Ile
Leu His Thr Leu
Leu Ile His Thr
Leu Ile Thr His
Leu Leu His Thr
Leu Leu Thr His
Leu Thr His Ile
Leu Thr His Leu
Leu Thr Ile His
Leu Thr Leu His
Thr His Ile Ile
Thr His Ile Leu
Thr His Leu Ile
Thr His Leu Leu
Thr Ile His Ile
Thr Ile His Leu
Thr Ile Ile His
Thr Ile Leu His
Thr Leu His Ile
Thr Leu His Leu
Thr Leu Ile His
Thr Leu Leu His
VD 2716
VD 2656
S,S,S-tris(2-ethylhexyl)phosphorotrithioate
C24H51OPS3 (482.28394860000003)
Alectinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
[3-carboxy-2-[(4Z,8E,10E,12E)-17-carboxy-7,14-dihydroxyheptadeca-4,8,10,12-tetraenoyl]oxypropyl]-trimethylazanium
C25H40NO8+ (482.27537800000005)
[(1S)-7-methoxy-9-methyl-1-[[4-(2-pyridinyl)phenyl]methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
[(1R)-7-methoxy-9-methyl-1-[[4-(2-pyridinyl)phenyl]methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
2-methylpropyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-methylpropyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
2-methylpropyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-methylpropyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-methylpropyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-methylpropyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
2-methylpropyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(7E,16Z)-(1S,3R)-23-thia-24,24b-clycobenzyl-19-nor-24a,24b-dihomo-9,10-seco-5,7,16-cholestatriene-1,3,25-triol
(7E,16Z)-(1S,3R,20R)-23-thia-24,24b-benzyl-19-nor-24a,24b-dihomo-9,10-seco-5,7,16-cholestatriene-1,3,25-triol
decyl beta-D-maltopyranoside
C22H42O11 (482.27269820000004)
A glycoside resulting from attachment of a decyl group to the reducing-end anomeric centre of a beta-maltose molecule.